A complex secretory program orchestrated by the inflammasome controls paracrine senescence
Open accessThe DOI matches its Crossref record; 53 of the 54 references it cites were found in a registry or an index; 20 of the 36 sources its claims cite were checked for support.
Abstract
Oncogene-induced senescence (OIS) is crucial for tumour suppression. Senescent cells implement a complex pro-inflammatory response termed the senescence-associated secretory phenotype (SASP). The SASP reinforces senescence, activates immune surveillance and paradoxically also has pro-tumorigenic properties. Here, we present evidence that the SASP can also induce paracrine senescence in normal cells both in culture and in human and mouse models of OIS in vivo. Coupling quantitative proteomics with small-molecule screens, we identified multiple SASP components mediating paracrine senescence, including TGF-β family ligands, VEGF, CCL2 and CCL20. Amongst them, TGF-β ligands play a major role by regulating p15(INK4b) and p21(CIP1). Expression of the SASP is controlled by inflammasome-mediated IL-1 signalling. The inflammasome and IL-1 signalling are activated in senescent cells and IL-1α expression can reproduce SASP activation, resulting in senescence. Our results demonstrate that the SASP can cause paracrine senescence and impact on tumour suppression and senescence in vivo.
Overview
CoChat Summary
## TL;DR
Cells undergoing oncogene-induced senescence (OIS) can transmit senescence to neighboring normal cells through secreted SASP factors, creating a stable paracrine senescence state in culture and in vivo. The paper identifies TGFβ family ligands and IL-1/inflammasome signaling as key regulators of this process.
## Key findings
- Normal IMR90 fibroblasts and HMECs became growth-arrested when co-cultured with OIS cells; the effect was transmitted through transwells and conditioned media, showing it was mediated by soluble factors rather than direct contact.
- Paracrine senescence resembled full senescence: normal cells showed increased DNA/oxidative damage, p16^INK4a^, p21^CIP1^, and SASP markers; gene-expression profiles of OIS and paracrine senescence were highly correlated and clustered together.
- Quantitative proteomics and a 78-compound screen implicated multiple SASP components in paracrine senescence, including TGFβ family ligands, VEGF, CCL2, and CCL20; blocking VEGFR2/FLT3, TGFBR1, or CCR2 partially impaired the arrest.
- The paper reports specific in vivo evidence of paracrine senescence: p21^CIP1^+/p16^INK4a^ cells were found near OIS lesions in mouse liver and skin, and in human serrated sessile adenomas the stromal p21^CIP1^/Ki-67^- signal was significantly increased near lesions (p = 0.03), with a separate comparison reporting p = 4.6 × 10^-5^ for p21^CIP1^ positive/Ki67 negative stromal cells.
## Methods
- Co-culture, transwell, conditioned-media, and cluster assays were used in human IMR90 fibroblasts and HMECs; OIS was induced with ER:RAS, MEK:ER, or related oncogenic constructs activated by 4OHT.
- Secretome analysis used SILAC-based quantitative proteomics, followed by a 78-compound receptor/pathway screen, RNAi knockdown, RT-qPCR, microarrays, GSEA, immunofluorescence/high-content analysis, and assays for BrdU, SA-β-Gal, caspase-1, and antibody arrays.
- In vivo validation used mouse OIS models including Nras-driven hepatocyte senescence, K5-Sos/Egfr^wa2/+^ skin papillomas, and Pdx1-Cre Kras^G12D^ pancreatic lesions, plus human SSA tissue IHC.
## Limitations
- The paper itself notes that “the nature of these cells and the functional implications of paracrine senescence remain open questions for future studies.”
- It also states that not all cells surrounding preneoplastic lesions undergo paracrine senescence; it proposes possible explanations such as soluble-factor gradients and cell-type susceptibility, but these are not experimentally resolved here.
- Evident from the text: many mechanistic and inhibitor results are partial (“partially rescued,” “partially prevented”), so the study does not identify a single exclusive mediator of paracrine senescence.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
15 Valid · 1 Not valid · 7 Not checked · 78 Own results and interpretations
Every source the paper cites for this claim was checked and supports it.
In the paper
“a transcriptional signature associated with senescence 18 was significantly upregulated during paracrine senescence (Fig 3d).”
§ Current address: Edinburgh Cancer Research UK Centre, Institute of Genetics and Molecular Medicine, University of Edinburgh, Western General Hospital, Crewe Road South, Edinburgh EH4 2XR, UK > Paracrine senescence resembles a full senescence response
What the sources say
- Supportedcites [18] Fridman AL, Tainsky MA. Critical pathways in cellular senescence and immortalization revealed by gene expression profiling. Oncogene. 2008; 27:5975-87. [PubMed: 18711403] source
The 'Genomic approaches to identify senescence/immortalization genes and pathways' section describes gene-expression profiling that identifies genes and pathways associated with senescence. In the citing sentence, the citation identifies the senescence-associated transcriptional signature; the finding that it was significantly upregulated during paracrine senescence is attributed to the citing paper’s Fig. 3d, not to this source. No page number is available in our copy. (LLM, conf=0.87)
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Colon SSAs are mainly driven by activating BRAF mutations that trigger OIS 31,34,35 .”
§ Current address: Edinburgh Cancer Research UK Centre, Institute of Genetics and Molecular Medicine, University of Edinburgh, Western General Hospital, Crewe Road South, Edinburgh EH4 2XR, UK > Paracrine senescence is observed in mouse and human models of OIS in vivo
What the sources say
- Partly supportedcites [31] Carragher LA, et al. V600EBraf induces gastrointestinal crypt senescence and promotes tumour progression through enhanced CpG methylation of p16INK4a. EMBO Mol Med. 2010; 2:458-71. [PubMed: 20941790] sourceExperimental — accuracy not yet measured
The Discussion reports V600E BRAF mutations in approximately 70% of right-sided serrated hyperplastic polyps and serrated adenomas, supporting a major role for BRAF in the serrated pathway. The Results show that V600E Braf induces senescence in mouse small-intestinal crypts, but do not establish that BRAF mutations trigger OIS in human colon sessile serrated adenomas. (LLM, conf=0.87)
- Partly supportedcites [34] Kriegl L, et al. Up and downregulation of p16(Ink4a) expression in BRAF-mutated polyps/ adenomas indicates a senescence barrier in the serrated route to colon cancer. Modern Pathology. 2011; 24:1015-22. [PubMed: 21423154] sourceExperimental — accuracy not yet measured
The Discussion (page unavailable) says that initiating BRAF mutations might drive oncogene-induced senescence in human serrated polyps, and concludes that the data provide evidence for senescence in the BRAF-mutated serrated route. It does not establish that colon sessile serrated adenomas are mainly driven by BRAF mutations: the study selected BRAF-mutated lesions for its final analysis, and its proposed causal link is hedged. (LLM, conf=0.85)
- Not checked — no full text of the sourcecites [35] Bennecke M, et al. Ink4a/Arf and oncogene-induced senescence prevent tumor progression during alternative colorectal tumorigenesis. Cancer Cell. 2010; 18:135-46. [PubMed: 20708155] source
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“A signature derived from IMR90 cells undergoing paracrine senescence is found enriched in mouse PANIN 44 and human serrated sessile adenomas (SSA) 36 .”
§ Current address: Edinburgh Cancer Research UK Centre, Institute of Genetics and Molecular Medicine, University of Edinburgh, Western General Hospital, Crewe Road South, Edinburgh EH4 2XR, UK > REFERENCES
What the sources say
- Partly supportedcites [44] Ling J, et al. KrasG12D-induced IKK2/beta/NF-kappaB activation by IL-1alpha and p62 feedforward loops is required for development of pancreatic ductal adenocarcinoma. Cancer Cell. 2012; 21:105-20. [PubMed: 22264792] sourceExperimental — accuracy not yet measured
The Results section, “Inhibition of Key Proinflammatory Cytokines,” reports gene-expression profiles from mouse PanIN, so this paper provides the mouse PanIN data cited as reference 44. It does not report testing or finding enrichment of an IMR90 paracrine-senescence signature in those profiles. The SSA finding is attached to a different citation (36), not this source. (LLM, conf=0.79)
- Not checked — no full text of the sourcecites [36] Caruso M, et al. Over-expression of cathepsin E and trefoil factor 1 in sessile serrated adenomas of the colorectum identified by gene expression analysis. Virchows Archiv. 2009; 454:291-302. [PubMed: 19172291] source
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“we identified multiple SASP components mediating paracrine senescence, including TGF β family ligands, VEGF, CCL2 and CCL20.”
- Also stated in: § Abstract · plain
“Coupling quantitative proteomics with small molecule screens, we identified multiple SASP components mediating paracrine senescence, including TGF β family ligands, VEGF, CCL2 and CCL20.”
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Also stated in: § Abstract · plain
The paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“Expression of the SASP is controlled by inflammasome-mediated IL-1 signalling.”
states a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: unclear — It is unclear why the paper says it holds.
54 more claims
Create a free account to see all 101 claims and every source verdict.
- Probably not a substantial claim. 20
- It may state two separate claims as one. 21
- The quote only partly states this claim. 3
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The senescent cell fate can be triggered by a number of stressors including DNA damage, cancerous mutations or oncogene activation, mitochondrial dysfunction, reactive metabolites, hyperoxia or hypoxia, proteotoxic stress, extracellular signals, infections, mechanical or shear stresses that deform cells, resistance exercise and factors secreted by other senescent cells18,38–47.”
From Cellular senescence and senolytics: the path to the clinic (2022) · cites this paper as [39]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The inflammasome, a multiprotein complex comprising caspase 1 and key regulators of the defence mechanisms against pathogens117, and Toll-like receptors, which regulate the inflammasome, have been reported to promote maturation and secretion of SASP factors during OIS73,118.”
From Cellular senescence in ageing: from mechanisms to therapeutic opportunities (2021) · cites this paper as [73]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In addition, specific SASP components, either soluble or in extracellular vesicles186, can induce senescence in a paracrine manner — which includes DDR activation73,83.”
From Cellular senescence in ageing: from mechanisms to therapeutic opportunities (2021) · cites this paper as [73]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Upstream signals triggering SASP activation are multiple and differ depending on the senescence inducer but include DNA damage, cytoplasmic chromatin fragments (CCFs) that trigger a type 1 interferon response, and damage-associated molecular patterns (DAMPs) that activate the inflammasome (Acosta et al., 2013; Davalos et al., 2013; Li and Chen, 2018).”
From Cellular Senescence: Defining a Path Forward (2019) · cites this paper as Acosta et al., 2013
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Higher secretion of SASP factors is also associated with an enhanced immune response, leading to inflammation which may promote tumorigenesis (Acosta et al., 2013).”
From Single senescent cell sequencing reveals heterogeneity in senescent cells induced by telomere erosion (2019) · cites this paper as Acosta et al., 2013
Experimental — accuracy not yet measured
47 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
The serial cultivation of human diploid cell strains
Hayflick, L., & Moorhead, P. S. (1961) · Experimental Cell Research · doi:10.1016/0014-4827(61)90192-6 · Cited by 8,508
The limited in vitro lifetime of human diploid cell strains
Hayflick, L. (1965) · Experimental Cell Research · doi:10.1016/0014-4827(65)90211-9 · Cited by 5,876
Schroder, K., & Tschopp, J. (2010) · Cell · doi:10.1016/j.cell.2010.01.040 · Cited by 5,475
Cellular senescence: when bad things happen to good cells
Campisi, J., & d'Adda di Fagagna, F. (2007) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2233 · Cited by 4,441
Massagué, J. (2008) · Cell · doi:10.1016/j.cell.2008.07.001 · Cited by 3,907
Clearance of p16Ink4a-positive senescent cells delays ageing-associated disorders
Baker, D. J., Wijshake, T., Tchkonia, T., LeBrasseur, N. K., Childs, B. G., van de Sluis, B., Kirkland, J. L., & van Deursen, J. M. (2011) · Nature · doi:10.1038/nature10600 · Cited by 3,670
Senescence and tumour clearance is triggered by p53 restoration in murine liver carcinomas
Xue, W., Zender, L., Miething, C., Dickins, R. A., Hernando, E., Krizhanovsky, V., Cordon-Cardo, C., & Lowe, S. W. (2007) · Nature · doi:10.1038/nature05529 · Cited by 2,473
Self-citationPreinvasive and invasive ductal pancreatic cancer and its early detection in the mouse
Hingorani, S. R., Petricoin, E. F., Maitra, A., Rajapakse, V., King, C., Jacobetz, M. A., Ross, S., Conrads, T. P., Veenstra, T. D., Hitt, B. A., et al. (2003) · Cancer Cell · doi:10.1016/s1535-6108(03)00309-x · Cited by 2,471
Inflammasomes in health and disease
Strowig, T., Henao-Mejia, J., Elinav, E., & Flavell, R. (2012) · Nature · doi:10.1038/nature10759 · Cited by 2,230
Oncogene-Induced Senescence Relayed by an Interleukin-Dependent Inflammatory Network
Kuilman, T., Michaloglou, C., Vredeveld, L. C. W., Douma, S., van Doorn, R., Desmet, C. J., Aarden, L. A., Mooi, W. J., & Peeper, D. S. (2008) · Cell · doi:10.1016/j.cell.2008.03.039 · Cited by 2,086
Cited by
Items 1,201–1,300 of 2,275
Stress-induced cellular senescence contributes to chronic inflammation and cancer progression.
KOBASHIGAWA, S., M. SAKAGUCHI, Y., MASUNAGA, S., & MORI, E. (2019) · Thermal Medicine · doi:10.3191/thermalmed.35.41 · Cited by 18
“In addition, Acosta et al.13) established the necessity of chemokine receptor CXCR2 in the establishment of cellular senescence.”
BackgroundSalminen, A. (2024) · Biogerontology · doi:10.1007/s10522-024-10114-w · Cited by 29
“Chemokines are well characterized SASP factors secreted by pro-inflammatory senescent cells (Rodier et al. 2009; Freund et al. 2010; Acosta et al. 2013).”
BackgroundVenkataraman, A., Kordic, I., Li, J., Zhang, N. Y., Bharadwaj, N. S., Fang, Z., Das, S., & Coskun, A. F. (2024) · npj Aging · doi:10.1038/s41514-024-00178-w · Cited by 23
Restoration of hair follicle inductive properties by depletion of senescent cells
Pappalardo, A., Kim, J. Y., Abaci, H. E., & Christiano, A. M. (2024) · Aging Cell · doi:10.1111/acel.14353 · Cited by 21
“In light of our data, it is likely that the SASPs secreted by senescent DPs act in a paracrine manner (Acosta et al., 2013) on the neighboring non-senescent DPs leading to loss of hair inductivity, and that some of these SASPs may have different effects on other cell types within the HF, such as…”
Cellular senescence in tumor immune escape: Mechanisms, implications, and therapeutic potential
You, L., & Wu, Q. (2025) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2025.104628 · Cited by 21
From Neuron‐Centric to Glia‐Centric: How Aging Glial Networks Drive Neurodegenerative Disease
Hayashide, L. D. S., Pessoa, B., Dias, G. R., Pontes, B., Pinto, R. S., & Diniz, L. P. (2026) · Journal of Neurochemistry · doi:10.1111/jnc.70361 · Cited by 21
“In the CNS, SASP factors released by senescent glial cells can amplify neuroin-flammatory signaling, promote paracrine senescence, and facilitate the propagation of neurodegenerative pathology (Acosta et al. 2013).”
A large-scale CRISPR screen and identification of essential genes in cellular senescence bypass
Liu, X., Wei, L., Dong, Q., Liu, L., Zhang, M. Q., Xie, Z., & Wang, X. (2019) · Aging · doi:10.18632/aging.102034 · Cited by 21
“45 SASP genes identified in previous studies [30, 31] were significantly elevated in senescent cells compared with growing cells (Supplementary Table 3), and the expression of these genes differed across the senescence bypass cells (Figure 4D, 4E).”
BackgroundMa, Y., Li, S., Ye, S., Hu, D., Wei, L. J., & Xiao, F. (2022) · Ecotoxicology and Environmental Safety · doi:10.1016/j.ecoenv.2022.113645 · Cited by 21
Alcohol use disorder as a potential risk factor for COVID ‐19 severity: A narrative review
Forsyth, C. B., Voigt, R. M., Swanson, G. R., Bishehsari, F., Shaikh, M. W., Zhang, L., Engen, P. A., & Keshavarzian, A. (2022) · Alcoholism Clinical and Experimental Research · doi:10.1111/acer.14936 · Cited by 21
An evaluation of aging measures: from biomarkers to clocks
Wang, Q., Hou, T., Wang, Q., He, J., Wang, L., Si, J., & Chen, S. (2022) · Biogerontology · doi:10.1007/s10522-022-09997-4 · Cited by 19
“Acosta et al. used a combination of biomarkers to validate the cells were senescence, including the upregulated expression of p21, p16, and components of SASP (Acosta et al. 2013).”
BackgroundInfluentialIron Metabolism in Cancer and Senescence: A Cellular Perspective
Crescenzi, E., Leonardi, A., & Pacifico, F. (2023) · Biology · doi:10.3390/biology12070989 · Cited by 20
“Senescent cells can spread the senescent phenotype to neighboring proliferating cells via secreted SASP (senescence-associated secretory phenotype) factors, a process referred to as paracrine senescence [68].”
BackgroundKong, S. H., Ma, L., Yuan, Q., Liu, X., Han, Y., Xiang, W., Liu, D., Zhang, Y., & Lü, J. (2023) · Cell Death Discovery · doi:10.1038/s41420-023-01591-y · Cited by 22
“Many cancer treatment drugs can cause senescence in different cancer cells during the treatment process [6], and cells display senescence-associated secretory phenotype (SASP) [7, 8].”
Wang, S., Heng, K., Song, X., Zhai, J., Zhang, H., & Geng, Q. (2023) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.202300330 · Cited by 19
Chen, M., Wu, G., Lu, Y., Sun, S., Zhao, Y., Pan, X., Chen, W., Xu, J., Qiu, H., He, W., et al. (2024) · Molecular Therapy · doi:10.1016/j.ymthe.2024.04.002 · Cited by 19
Yusri, K., Kumar, S., Fong, S., Gruber, J., & Sorrentino, V. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25126793 · Cited by 25
“…processes: replicative senescence, caused by telomere shortening, and stress-induced premature senescence, triggered by various stressors including DNA damage, oncogene activation, oxidative stress, chemotherapy, mitochondrial dysfunction, epigenetic changes, and paracrine signaling [112–116].”
BackgroundCellular senescence: A novel therapeutic target for central nervous system diseases
Lei, S.-Y., Qu, Y., Yang, Y.-Q., Liu, J., Zhang, Y.-F., Zhou, S., He, Q., Jin, H., Yang, Y., & Guo, Z. (2024) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2024.117311 · Cited by 23
Self-citationKaplon, J., Cornelia, H.-H., Gao, L. Y., Meissl, K., Verdegaal, E. M. E., van der Burg, S. H., van Doorn, R., & Peeper, D. S. (2014) · Pigment Cell & Melanoma Research · doi:10.1111/pcmr.12248 · Cited by 21
“Further supporting a cell non-autonomous role for senescence, it was recently shown that this program can be brought about also in a paracrine fashion (Acosta et al., 2013).”
BackgroundDetecting the Senescence-Associated Secretory Phenotype (SASP) by High Content Microscopy Analysis
Hari, P., & Acosta, J. C. (2016) · Methods in molecular biology · doi:10.1007/978-1-4939-6670-7_9 · Cited by 21
Self-citationThe induction of the fibroblast extracellular senescence metabolome is a dynamic process
James, E. N., Bennett, M. H., & Parkinson, E. K. (2018) · Scientific Reports · doi:10.1038/s41598-018-29809-5 · Cited by 18
Herb-Derived Products: Natural Tools to Delay and Counteract Stem Cell Senescence
Abruzzo, P. M., Canaider, S., Pizzuti, V., Pampanella, L., Casadei, R., Facchin, F., & Ventura, C. (2020) · Stem Cells International · doi:10.1155/2020/8827038 · Cited by 21
“In particular, IL-1α is an upstream master regulator of the SASP, while IL-1β and TGF-β mediate senescence spread, with the downstream products IL-6 and IL-8 reinforcing senescence in an autocrine fashion [50, 51].”
BackgroundKirsch‐Volders, M., & Fenech, M. F. (2021) · Mutation Research/Reviews in Mutation Research · doi:10.1016/j.mrrev.2021.108395 · Cited by 20
The Dual Role of Senescence in Pancreatic Ductal Adenocarcinoma
Porciuncula, A., Hajdu, C. H., & David, G. (2016) · Advances in cancer research · doi:10.1016/bs.acr.2016.05.006 · Cited by 20
Palikyras, S., Sofiadis, K., Stavropoulou, A., Danieli‐Mackay, A., Varamogianni‐Mamatsi, V., Hörl, D., Nasiscionyte, S., Zhu, Y., Papadionysiou, I., Papadakis, A., et al. (2024) · Aging Cell · doi:10.1111/acel.14083 · Cited by 17
“This is not only due to idiosyncratic cell-intrinsic properties (e.g., telomere attrition), but also a result of complex paracrine signaling via the SASP (Coppé et al., 2010).”
BackgroundInfluentialHudock, J., & Kenney, J. W. (2024) · PLoS ONE · doi:10.1371/journal.pone.0300227 · Cited by 21
Accelerated Cellular Senescence in Progressive Multiple Sclerosis: A Histopathological Study
Papadopoulos, D., Magliozzi, R., Bandiera, S., Cimignolo, I., Barusolo, E., Probert, L., Gorgoulis, V. G., Reynolds, R., & Nicholas, R. S. (2025) · Annals of Neurology · doi:10.1002/ana.27195 · Cited by 19
“18,19 In addition, senescent cells may also accumulate over time under conditions of persistent tissue damage or in aged tissues where their immune-mediated clearance fails.”
Ruff, Z. D. V., Miller, M. J., Moro, T., Reidy, P. T., Ebert, S. M., Volpi, E., Adams, C. M., & Rasmussen, B. B. (2025) · GeroScience · doi:10.1007/s11357-025-01564-2 · Cited by 22
“The SASP consists of secreted factors, including inter-leukins, chemokines, proteases, and matrix remodeling proteins that negatively affect tissue function at a local and systemic level [129–131].”
Cellular Senescence, Inflammaging and Cardiovascular Disease
Zanders, L., Arifaj, D., Wagner, J. U. G., & Dimmeler, S. (2026) · Immunological Reviews · doi:10.1111/imr.70084 · Cited by 33
Daniel, L., Tassery, M., Lateur, C., Thierry, A., Herbelin, A., Gombert, J., & Barbarin, A. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.674016 · Cited by 19
Morales-Valencia, J., & David, G. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.747822 · Cited by 21
“The SASP has been suggested to bear antitumorigenic effects including reinforcement of senescence in an autocrine and paracrine manner (22, 27).”
BackgroundZayed, M., & Iohara, K. (2022) · Current Molecular Medicine · doi:10.2174/1566524022666220520124630 · Cited by 18
Mettl14-driven senescence-associated secretory phenotype facilitates somatic cell reprogramming
Xi, C., Sun, J., Xu, X., Wu, Y., Kou, X., Zhao, Y., Shen, J., Dong, Y., Chen, K., Su, Z., et al. (2022) · Stem Cell Reports · doi:10.1016/j.stemcr.2022.06.012 · Cited by 17
“In addition, senescent cells exhibit noncellular autonomous activities, such as secretion of inflammatory cytokines and chemokines (Acosta et al., 2013), which are together defined as the senescence-associated secretory phenotype (SASP) (Lopes-Paciencia et al.”
BackgroundRecent Advances in Strategies for Imaging Detection and Intervention of Cellular Senescence
Li, J., Bi, Z., Wang, L., Xia, Y., Xie, Y., & Liu, Y. (2022) · ChemBioChem · doi:10.1002/cbic.202200364 · Cited by 19
Transposon control as a checkpoint for tissue regeneration
Angileri, K. M., Bagia, N. A., & Feschotte, C. (2022) · Development · doi:10.1242/dev.191957 · Cited by 15
Nakagawa, M., Asahina, Y., Kakinuma, S., & Okamoto, R. (2022) · Journal of Gastroenterology · doi:10.1007/s00535-022-01940-1 · Cited by 19
“Senescence can promote a precancerous niche through the production of senescenceassociated secretory phenotype (SASP) which can promote adjacent cells to become senescent [27, 29, 30].”
BackgroundWu, S. K., Ariffin, J. K., Tay, S. C., & Picone, R. (2023) · Aging Cell · doi:10.1111/acel.13766 · Cited by 22
“Accordingly, we observed the enrichment of hypoxia- induced genes and a HIF- 1α activation signature in published data sets (Acosta et al., 2013), whereby senescence was induced by oncogene activation (FDR q 0.001, Figure S5h, i).”
BackgroundMethodInfluentialSenescence-associated exosomes transfer miRNA-induced fibrosis to neighboring cells
Lee, A. H., Ghosh, D., Koh, I. L., & Dawson, M. (2023) · Aging · doi:10.18632/aging.204539 · Cited by 28
Senescence in the ageing skin: a new focus on m TORC 1 and the lysosome
Smith, P., & Carroll, B. (2024) · FEBS Journal · doi:10.1111/febs.17281 · Cited by 21
“The inflammatory factors of the fibroblast SASP have been shown in vitro to have an autocrine role in maintaining cell cycle arrest [42], as well as paracrine roles in inducing neighbouring cell senescence, which is corroborated by in vivo studies [123].”
Mizutani, T., Ishizaka, A., & Furuichi, Y. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.657155 · Cited by 20
The Potential Role of Senescence As a Modulator of Platelets and Tumorigenesis
Valenzuela, C. A., Quintanilla, R., Moore‐Carrasco, R., & Brown, N. E. (2017) · Frontiers in Oncology · doi:10.3389/fonc.2017.00188 · Cited by 18
“Thus, some components of the SASP can propagate or reinforce the senescent phenotype through autocrine or paracrine mechanisms, leading to further secretion and amplification of the SASP (105).”
BackgroundSogabe, Y., Seno, H., Yamamoto, T., & Yamada, Y. (2018) · Cancer Science · doi:10.1111/cas.13731 · Cited by 17
Senescence utilises inflammatory caspases to drive SASP
Wiggins, K. A., & Clarke, M. C. H. (2019) · Aging · doi:10.18632/aging.102031 · Cited by 17
Carpenter, V. J., Patel, B. B., Autorino, R., Smith, S. C., Gewirtz, D. A., & Saleh, T. (2020) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2020.188424 · Cited by 18
Genes and pathways involved in senescence bypass identified by functional genetic screens
Roupakia, E., Markopoulos, G. S., & Kolettas, E. (2021) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2021.111432 · Cited by 20
Aging and Cancer: The Waning of Community Bonds
Laconi, E., Cheri, S., Fanti, M., & Marongiu, F. (2021) · Cells · doi:10.3390/cells10092269 · Cited by 20
“, fueling low grade inflammation [24,25]).”
Herrmann, J., Xia, M., Gummi, M. R., Greco, A., Schacke, A., van der Giet, M., Tölle, M., & Schuchardt, M. (2021) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2021.752305 · Cited by 22
“, Il-1β was investigated in cell culture and animal models (33).”
BackgroundKishi, S., Bayliss, P. E., & Hanai, J. (2014) · Translational research · doi:10.1016/j.trsl.2014.05.007 · Cited by 18
Camorani, S., Cerchia, L., Fedele, M., Erba, E., D’Incalci, M., & Crescenzi, E. (2018) · Oncotarget · doi:10.18632/oncotarget.24961 · Cited by 20
“Another beneficial function of the SASP is paracrine stimulation of senescence in neighboring cells [37].”
BackgroundGunaratna, R. T., Santos, A., Luo, L., Nagi, C. S., Lambertz, I. U., Spier, M. E., Conti, C. J., & Fuchs‐Young, R. (2019) · Oncogene · doi:10.1038/s41388-018-0630-4 · Cited by 18
Chen, M., Chen, W., Sun, S., Lu, Y., Wu, G., Xu, H., Yang, H., Li, C., He, W., Xu, M., et al. (2024) · Journal of Advanced Research · doi:10.1016/j.jare.2024.08.034 · Cited by 17
The Role of Endothelial Senescence in the Pathogenesis of Diabetic Retinopathy
Gandhi, M., Haider, S., Chang, H. Z. Y., & Kazlauskas, A. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26115211 · Cited by 19
“IL-1-mediated inflammasome activation in senescent cells amplifies SASP and triggers p21 CIP1 and p16 INK4b expression in neighboring cells, propagating senescence in a non-cell-autonomous fashion [67].”
Potential Role of Inflammasomes in Aging
Lee, G., & Lee, G.-S. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26146768 · Cited by 20
“By interrupting upstream activation, these approaches can simultaneously limit IL-1 β and IL-18 secretion, pyroptosis, and the SASP-driven spread of senescence [68].”
InfluentialImplications of Cellular Aging in Cardiac Reprogramming
Passaro, F., & Testa, G. (2018) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2018.00043 · Cited by 15
“Nevertheless, SASP components may also induce senescence in surrounding cells in a paracrine manner, through a mechanism involving Reactive Oxygen Species (ROS) generation and DNA damage (41, 42).”
BackgroundTilman, G., Bouzin, C., Aydın, S., Tamirou, F., Galant, C., Coulie, P. G., Houssiau, F., Lauwerys, B., & Limaye, N. (2021) · RMD Open · doi:10.1136/rmdopen-2021-001844 · Cited by 19
“Several proinflammatory factors have been implicated in senescence induction, 13 14 including interferon-β 13 that has been linked to the senescent phenotype of bone marrow mesenchymal stem cells from patients with SLE.”
Potential role of cellular senescence in pulmonary arterial hypertension
Liu, L., Wei, Y., Giunta, S., He, Q., & Xia, S. (2022) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/1440-1681.13696 · Cited by 21
“The SASP drives the paracrine senescence mainly through secreted proteins, like IL-1α, TGF-β, NF-κB.26,27 More importantly, the SASP has been considered to be involved in the recruitment of immune cells to the injury site,28,29 and these recruited immune cells have the ability to clear away senescent cells.”
BackgroundGuerrero, A., Innes, A. J., Roux, P., Buisman, S. C., Jung, J., Ortet, L., Moiseeva, V., Wagner, V., Robinson, L. J., Ausema, A., et al. (2022) · Nature Aging · doi:10.1038/s43587-022-00279-9 · Cited by 15
“As a positive control for preventing senescence induction, we treated cells undergoing senescence with 4 µ M of TGF-b RI kinase inhibitor II (TGFBi), which resulted in a higher percentage of cells incorporating BrdU when compared to untreated cells 18 (Fig.”
BackgroundMethodInfluentialSelf-citationThe microbiota and aging microenvironment in pancreatic cancer: Cell origin and fate
Chen, Z., Wang, Z., Du, Y., Shi, H., & Zhou, W. (2022) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2022.188826 · Cited by 17
A focused natural compound screen reveals senolytic and senostatic effects of Isatis tinctoria
Kim, E.-J., Woo, J., Shin, S., Choi, H., Kim, Y. S., Kim, J., & Kang, C. (2022) · Animal Cells and Systems · doi:10.1080/19768354.2022.2143895 · Cited by 17
“…factors, and proteases that mediate pleiotropic effects of senescence, including paracrine senescence, tissue repair, immune surveillance, chronic inflammation, and tissue aging (Coppe et al. 2008; Coppe et al. 2010; Acosta et al. 2013; Kang et al. 2015; Birch and Gil 2020; Borghesan et al. 2020).”
BackgroundLi, W., Abdul, Y., Chandran, R., Jamil, S., Ward, R., Abdelsaid, M. A., Dong, G., Fagan, S. C., & Ergul, A. (2022) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00490.2022 · Cited by 17
Cellular Senescence and Ageing
Reed, R., & Miwa, S. (2023) · Sub-cellular biochemistry/Subcellular biochemistry · doi:10.1007/978-3-031-21410-3_7 · Cited by 16
Aging-Related Mechanisms Contribute to Corticosteroid Insensitivity in Elderly Asthma
Ford, M. L., Ruwanpathirana, A., Lewis, B. W., & Britt, R. D. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24076347 · Cited by 20
“Chest expansion has also been found to be inversely related to age [52].”
BackgroundSenescent macrophages: A new “old” player in lung cancer development
Zhou, L., & Ruscetti, M. A. (2023) · Cancer Cell · doi:10.1016/j.ccell.2023.05.008 · Cited by 19
The importance of integrated therapies on cancer: Silibinin, an old and new molecule
Roca, E., Colloca, G. A., Lombardo, F., Bellieni, A., Cucinella, A., Madonia, G., Martinelli, L., Damiani, M. E., Zampieri, I., & Santo, A. (2024) · Oncotarget · doi:10.18632/oncotarget.28587 · Cited by 17
“This suggests that inflammaging is propagated by the secretion of damaged cellular components produced by compromised, stressed, or senescent cells and organelles during a pathological event [61], transmitted in a paracrine fashion by activation of IL-1 signaling [62].”
BackgroundTrajectories of cardiovascular ageing—from molecular mechanisms to clinical implementation
Ministrini, S., Wenzl, F. A., Lüscher, T. F., & Camici, G. G. (2024) · Cardiovascular Research · doi:10.1093/cvr/cvae178 · Cited by 30
“88 With ageing, cells are more prone to enter senescence, because of telomere attrition and accumulation of molecular damages; at the same time, with ageing, the removal of senescent cells becomes less and less efficient, resulting in their progressive accumulation within the tissues.”
Ye, Z., Che, H.-B., Zhang, T.-Y., Chen, Z., Tian, L., & Gu, D.-N. (2020) · Oncology Letters · doi:10.3892/ol.2020.12400 · Cited by 21
“Lastly, senescent tumor cells are metabolically active, and can secrete cytokines and other paracrine factors, which feed and stimulate the growth of adjacent cells (34).”
BackgroundSantos, J. C., Ribeiro, M. L., & Gambero, A. (2021) · Frontiers in Physiology · doi:10.3389/fphys.2020.612268 · Cited by 16
Liu, Z., Zhang, D., Liu, C., Li, G., Chen, H., Ling, H. H., Zhang, F., Huang, D., Wang, X., Liu, Y., et al. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.659184 · Cited by 18
“IL1B, belonging to the IL1 system, can drive senescence-associated secretory phenotypes (SASPs), which may affect immune cell activation and induce neutrophil accumulation (76, 77).”
BackgroundFeunteun, J., Ostyn, P., & Delaloge, S. (2022) · iScience · doi:10.1016/j.isci.2022.104217 · Cited by 20
Succoio, M., Comegna, M., DˈAmbrosio, C., Scaloni, A., Cimino, F., & Faraonio, R. (2015) · Journal of Proteomics · doi:10.1016/j.jprot.2015.07.010 · Cited by 17
“By producing a chronic senescence-associated secretory phenotype (SASP), senescent cells can also trigger paracrine senescence in neighboring cells, interfere with architecture/function of tissues, and stimulate inflammatory phenotypes paradoxically promoting a pro-oncogenic environment [16,17].”
BackgroundGRSF1 is an age-related regulator of senescence
Kim, S., Chun, M., Wan, J., Lee, C. D., Yen, K., & Cohen, P. (2019) · Scientific Reports · doi:10.1038/s41598-019-42064-6 · Cited by 22
Escoll, P., Ranz, I., Muñoz-Antón, N., Rym, A. M. V. D., Álvarez‐Mon, M., Martínez-Alonso, C., Sanz, E., & de-la-Hera, A. (2015) · Mediators of Inflammation · doi:10.1155/2015/347965 · Cited by 18
p21 facilitates chronic lung inflammation via epithelial and endothelial cells
Levi, N., Papismadov, N., Majewska, J., Roitman, L., Wigoda, N., Eilam, R., Tsoory, M., Rotkopf, R., Ovadya, Y., Akiva, H., et al. (2023) · Aging · doi:10.18632/aging.204622 · Cited by 15
“This process is mediated by expression and secretion of proteins, members of the senescence associated secretory phenotype (SASP), which leads to chronic activation of immune responses in the lungs [40–45].”
Targeting senescent cells in atherosclerosis: Pathways to novel therapies
Tian, Y., Shao, S., Feng, H., Zeng, R., Li, S., & Zhang, Q. (2024) · Ageing Research Reviews · doi:10.1016/j.arr.2024.102502 · Cited by 16
Physical training reduces cell senescence and associated insulin resistance in skeletal muscle
Podraza-Farhanieh, A., Spinelli, R., Zatterale, F., Nerstedt, A., Gogg, S., Blüher, M., & Smith, U. (2025) · Molecular Metabolism · doi:10.1016/j.molmet.2025.102130 · Cited by 19
“Importantly, SASP can propagate senescence to neighboring healthy cells [42].”
Mechanisms of endothelial senescence and vascular aging
Qiao, L., Qian, Z., Huang, Y., Yang, X. F., Yang, J., Xiao, N., Liang, G., Zhang, H., Fu, Y., Yan, L., et al. (2025) · Biogerontology · doi:10.1007/s10522-025-10279-y · Cited by 27
“Senescent endothelial cells secrete a variety of cytokines, such as plasminogen activator inhibitor 1 (PAI-1), interleukin-8 (IL-8), and IL-6 (Acosta et al. 2013), thereby further causing paracrine senescence (Acosta et al. 2013).”
InfluentialNonninger, T. J., Mak, J., Gerisch, B., Ramponi, V., Kawamura, K., Ripa, R., Schilling, K., Latza, C., Kölschbach, J., Serrano, M., et al. (2025) · Nature Aging · doi:10.1038/s43587-025-00911-4 · Cited by 25
“Of note, elevated Notch and TGFβ signaling are both considered hallmarks of senescent cells 40,41 , suggesting that their dysregulation in hlh-30 mutants could contribute to a senescence-like state.”
SIRT3-Mediated Mitochondrial Regulation and Driver Tissues in Systemic Aging
Šešelja, K., Šimunić, E., Sobočanec, S., Podgorski, I. I., Pinterić, M., Hadžija, M. P., Balog, T., & Belužić, R. (2025) · Genes · doi:10.3390/genes16121497 · Cited by 19
“In the early stages of senescence, the SASP is characterized by immunosuppressive and tissue-remodeling factors, including TGF-β , VEGF, PDGF, and MMPs, which promote matrix deposition, angiogenesis, and transient immune evasion [46–49].”
The autophagy-senescence axis as a threshold model of aging and therapeutic targeting
Bahar, M. E., Hwang, J. S., Lai, T. H., Akter, K.-M., Maulidi, R. F., & Kim, D. R. (2026) · Redox Biology · doi:10.1016/j.redox.2026.104079 · Cited by 25
“These vesicles then induce DNA damage responses and secondary senescence, commonly referred to as the bystander effect [34].”
Cellular senescence as a source of SARS‐CoV‐2 quasispecies
Karakasiliοtis, I., Lаgopati, N., Evangelou, K., & Gorgoulis, V. G. (2021) · FEBS Journal · doi:10.1111/febs.16230 · Cited by 15
Wuestefeld, A., Iakovleva, V., Yap, S. X. L., Ong, A. B. L., Huang, D. Q., Shuen, T. W. H., Toh, H. C., Dan, Y. Y., Zender, L., & Wüestefeld, T. (2022) · Cancer Research · doi:10.1158/0008-5472.can-22-1477 · Cited by 18
“This result supports the notion of paracrine senescence (8) on neighboring cells.”
Self-citationAndrogen Receptor Activation Induces Senescence in Thyroid Cancer Cells
Gupta, A., Carnazza, M. A., Jones, M., Darżynkiewicz, Z., Halicka, D. H., O'Connell, T. J., Zhao, H. L., Dadafarin, S., Shin, E. D., Schwarcz, M., et al. (2023) · Cancers · doi:10.3390/cancers15082198 · Cited by 18
“Numerous studies have noted that senescent cells can spread growth arrest and senescence to neighboring cells [47,48].”
BackgroundRaschick, M., Richter, A., Fischer, L., Knopf, L., Schult, A., Yakupov, R., Behnisch, G., Guttek, K., Düzel, E., Dunay, I. R., et al. (2023) · Journal of Neural Transmission · doi:10.1007/s00702-023-02638-1 · Cited by 18
“SASP is defined by senescence-induced increased secretion of pro-inflammatory molecules like cytokines or chemokines (Basisty et al. 2020) (see http://www.saspatlas.com/), which in turn induce senescence in neighboring cells (Nelson et al. 2012; Acosta et al. 2013).”
BackgroundCamps, J., Iftimie, S. M., Arenas, M., Castañé, H., Jiménez-Franco, A., Castro, A., & Joven, J. (2023) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2023.110553 · Cited by 16
Dynamics of redox signaling in aging via autophagy, inflammation, and senescence
Javali, P. S., Sekar, M., Kumar, A., & Thirumurugan, K. (2023) · Biogerontology · doi:10.1007/s10522-023-10040-3 · Cited by 18
“Discharge of chemical signals stimulate senescence of normal adjacent cells (Hubackova et al. 2012; Nelson et al. 2012; Acosta et al. 2013; Lagnado et al. 2021; Waters et al. 2021).”
BackgroundHodge, J., Robinson, J. L., & Mellott, A. J. (2023) · Tissue Engineering and Regenerative Medicine · doi:10.1007/s13770-023-00565-6 · Cited by 17
“Previous studies have shown that senescent cell populations, including MSCs, can impair the regenerative activity of surrounding cell populations in a number of ways, including the secretion of factors that induce senescence [59].”
BackgroundSenescence program and its reprogramming in pancreatic premalignancy
Yang, K., Li, X., & Xie, K. (2023) · Cell Death and Disease · doi:10.1038/s41419-023-06040-3 · Cited by 21
“Various components of the SASP can transmit senescence signals to the neighboring non-senescent cells and induce paracrine senescence [44].”
BackgroundBei, J., Miranda-Morales, E. G., Gan, Q., Qiu, Y., Husseinzadeh, S., Liew, J. Y., Chang, Q., Krishnan, B., Gaitas, A., Yuan, S., et al. (2023) · Journal of Alzheimer s Disease · doi:10.3233/jad-230347 · Cited by 22
“TheimpactsofSASPareexertedinautocrineand paracrine manners[45, 46].”
Therapy-induced normal tissue damage promotes breast cancer metastasis
Perkins, D. W., Steiner, I., Haider, S., Robertson, D. M., Buus, R., O’Leary, L., & Isacke, C. M. (2023) · iScience · doi:10.1016/j.isci.2023.108503 · Cited by 21
“, 2018); as well as Ccl2 (MCP1), a potent macrophage chemoattractant, reported to play a role in cancer progression (Acosta et al., 2013; Park et al., 2012; Sanoff et al., 2014), and the related factors Ccl7 (MCP3) and Ccl8 (MCP2).”
BackgroundParishin treatment alleviates cardiac aging in naturally aged mice
Zhou, S., Zhao, X., Wu, L., Ren, Y., Sun, L., Zhang, Q., Gong, C., Liu, Y., Xiang, L., Li, S., et al. (2023) · Heliyon · doi:10.1016/j.heliyon.2023.e22970 · Cited by 15
Sarandy, M. M., Gonçalves, R. V., & Valacchi, G. (2024) · Biomedicines · doi:10.3390/biomedicines12020348 · Cited by 19
“Senescent cells can maintain the synthesis of SASP markers such as IL-6, TGF-β , VEGF, CCL2, and CCL20, which can reinforce senescence in an autocrine and paracrine manner [39].”
BackgroundEndometrial senescence is mediated by interleukin 17 receptor B signaling
Kawamura, K., Matsumura, Y., Kawamura, T., Araki, H., Hamada, N., Kuramoto, K., Yagi, H., Onoyama, I., Asanoma, K., & Kato, K. (2024) · Cell Communication and Signaling · doi:10.1186/s12964-024-01740-5 · Cited by 22
“SASP factors induce senescence both in the cells themselves and in those that surround them via both autocrine and paracrine mechanisms, respectively [56, 57], as well as promoting chronic inflammation and carcinogenesis [56].”
BackgroundThe Regulation of Cellular Senescence in Cancer
Zhang, X., Gao, Y., Zhang, S., Wang, Y., Du, Y., Hao, S., & Ni, T. (2025) · Biomolecules · doi:10.3390/biom15030448 · Cited by 17
“To explore the relationship between senescence-related SASP and cancer, comparisons between senescent and control cells revealed differences in the distribution of two genes, METTL3 and METTL14 , which are closely related to SASP secretion.”
Aberrant signaling and senescence associated protein degradation
Ferbeyre, G. (2017) · Experimental Gerontology · doi:10.1016/j.exger.2017.06.016 · Cited by 16
Montero, J. A., Lorda-Diez, C. I., & Hurlé, J. M. (2020) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.593761 · Cited by 15
“The SASP is thought to reinforce and spread senescence and activates immune responses that eliminate senescent cells (Acosta et al., 2013; Muñoz-Espín and Serrano, 2014).”
BackgroundPirazzini, C., Azevedo, T., Baldelli, L., Bartoletti‐Stella, A., Buonaura, G. C., Molin, A. D., Dimitri, G. M., Doykov, I., Gómez‐Garre, P., Hägg, S., et al. (2020) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2020.111426 · Cited by 17
“The same propagation process applies also to the complex mixture of cytokines and pro-inflammatory molecules released by senescent cells and termed Senescence Associated Secretory Phenotype (SASP) (Acosta et al., 2013; Tchkonia et al., 2013).”
BackgroundToulassi, I. A., Saedi, U. A. A., Gutlapalli, S. D., Poudel, S., Kondapaneni, V., Zeb, M., & Cancarevic, I. (2021) · Cureus · doi:10.7759/cureus.12735 · Cited by 19
“Recent studies have shown senescent cells in atherosclerotic plaque secrete high levels of pro-atherogenic factors such as (matrix metalloprotein 12, matrix metalloprotein 13, interleukin 6 {IL-6}), proinflammatory cytokines, or chemokines with increased expression of senescence markers like (p53, p16, p21) [5-8].”
BackgroundArvia, R., Zakrzewska, K., Giovannelli, L., Ristori, S., Frediani, E., Rosso, M. D., Mocali, A., Stincarelli, M. A., Laurenzana, A., Fibbi, G., et al. (2021) · Rheumatology · doi:10.1093/rheumatology/keab904 · Cited by 22
GH and Senescence: A New Understanding of Adult GH Action
Chesnokova, V., & Melmed, S. K. (2021) · Journal of the Endocrine Society · doi:10.1210/jendso/bvab177 · Cited by 19
“SASP also induces bystander DNA damage and activates p16 and p21 along with chemokines and interleukins [20].”
BackgroundCai, D., Zhao, Z., Hu, J., Dai, X., Zhong, G., Gong, J., & Qi, F. (2022) · Frontiers in Surgery · doi:10.3389/fsurg.2022.836080 · Cited by 17
Xing, J., Chen, K., Gao, S., Pousse, M., Ying, Y., Wang, B., Chen, L., Wang, C., Wang, L., Hu, W., et al. (2023) · Aging Cell · doi:10.1111/acel.13780 · Cited by 19
“…associated secretory phenotype (SASP) involving the expression and secretion of inflammatory cytokines, growth factors, proteases, and other molecules that can alter tissue microenvironments and cell– cell interactions (Acosta et al., 2013; Correia- Melo et al., 2016; Wiley et al., 2016).”
BackgroundRecent Advances in Senolysis for Age-Related Diseases
Aratani, S., & Nakanishi, M. (2023) · Physiology · doi:10.1152/physiol.00003.2023 · Cited by 19
Metadata
- Authors
- Acosta, J. C., Banito, A., Wuestefeld, T., Georgilis, A., Janich, P., Morton, J. P., Athineos, D., Kang, T.-W., Lasitschka, F., Andrulis, M., Pascual, G., Morris, K. J., Khan, S., Jin, H., Dharmalingam, G., Snijders, A. P., Carroll, T., Capper, D., Pritchard, C., Inman, G. J., Longerich, T., Sansom, O. J., Benitah, S. A., Zender, L., & Gil, J.
- Affiliations
- Imperial College London (GB)
- Centre for Genomic Regulation (ES)
- Cancer Research UK Scotland Institute (GB)
- University of Tübingen (DE)
- German Cancer Research Center (DE)
- University of Leicester (GB)
- University of Dundee (GB)
- Corresponding author
- Gil, Jesús
- ORCID
- Acosta, Juan Carlos
- Banito, Ana
- Janich, Peggy
- Morton, Jennifer P.
- Athineos, Dimitris
- Lasitschka, Felix
- Andrulis, Mindaugas
- Pascual, Gloria
- Khan, Sadaf
- Jin, Hong
- Snijders, Ambrosius P.
- Carroll, Thomas
- Capper, David
- Pritchard, Catrin
- Inman, Gareth J.
- Longerich, Thomas
- Sansom, Owen J.
- Benitah, Salvador Aznar
- Zender, Lars
- Gil, Jesús
- Venue
- Nature Cell Biology
- Published
- 2013-06-16
- Volume
- 15
- Issue
- 8
- Pages
- 978-990
- ISSN
- 1465-7392 (ISSN-L)
- 1476-4679
- PMC
- PMC3732483
- OpenAlex
- W2140930678
- Semantic Scholar
- 59786bed7ce43f9317328cd82838f14d911e5dd4
- Cited by
- 2,278
- References
- 54
- Citations by year
- 2026: 247 · 2025: 225 · 2024: 232 · 2023: 240 · 2022: 264 · 2021: 250 · 2020: 202 · 2019: 154 · 2018: 119 · 2017: 107 · 2016: 89 · 2015: 79 · 2014: 56 · 2013: 13
- FWCI
- 54.88
- Type
- journal article
- Language
- en
- Update notices
- correction (2026-04-28)
- Open access
- green
- europepmc.org
- Licence
- www.springernature.com/gp/researchers/text-and-data-mining (tdm)
- www.springernature.com/gp/researchers/text-and-data-mining (vor)
- Locations
- Nature Cell Biology (publishedVersion)
- PubMed (publishedVersion)
- NERC Open Research Archive (Natural Environment Research Council) (acceptedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- RECERCAT (Consorci de Serveis Universitaris de Catalunya) (acceptedVersion, other-oa)
- Edinburgh Research Explorer (University of Edinburgh) (submittedVersion, other-oa)
- Repositori digital de la UPF (Universitat Pompeu Fabra) (submittedVersion)
- Spiral (Imperial College London) (submittedVersion)
- Funders
- Cancer Research UK (A7769, 13083, 11650, 12481)
- Medical Research Council
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Telomeres, Telomerase, and Senescence
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Aging › Genetics, Aging, and Longevity in Model Organisms
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Inflammasome and immune disorders
- Keywords
- oncogene-induced senescence, senescence-associated secretory phenotype, paracrine senescence, inflammasome, IL-1 signaling, TGF-beta ligands, vascular endothelial growth factor, MCP-1, CCL20, CDKN2B, p21, tumor suppression, senescence-associated secretome
- MeSH terms
- Animals, Colonic Neoplasms, Humans, Immunohistochemistry, Interleukin-1, Protein Binding, Signal Transduction, Gene Expression Regulation, Neoplastic, Cellular Senescence, Paracrine Communication, Models, Animal, Cell Line, Tumor, Mice, Transforming Growth Factor beta1, Inflammasomes
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-12, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-12 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.